Despite tremendous efforts, worldwide COVID-19 vaccination coverage is lagging. Dose-sparing
strategies for COVID-19 vaccines can increase vaccine availability to address the …

Systemic immune cell dynamics during coronavirus disease 2019 (COVID-19) are extensively
documented, but these are less well studied in the (upper) respiratory tract, where severe …

COVID-19, caused by SARS-CoV-2, can lead to severe inflammation and has been suggested
to induce autoimmune phenomena. Multiple studies have reported autoantibodies in …

Background Vaccines can be less immunogenic in people living with HIV (PLWH), but for
SARS-CoV-2 vaccinations this is unknown. In this study we set out to investigate, for the …

Objectives The COVID-19 pandemic increases healthcare worker (HCW) absenteeism. The
bacillus Calmette-Guérin (BCG) vaccine may provide non-specific protection against …

Rationale for review : The global yellow fever vaccine supply is insufficient to provide full-dose
vaccination to millions threatened by outbreaks. Given the excess of live-attenuated 17D …

Background Immunoglobulin G1 (IgG1) effector functions are impacted by the structure of
fragment crystallizable (Fc) tail-linked N-glycans. Low fucosylation levels on severe acute …

Background: Outbreaks of yellow fever and a frequently depleted vaccine stock increase
demand for a dose-sparing strategy. A fractional dose of 17D yellow fever virus (17D-YFV) …

Background Immunocompromised travelers to developing countries are thought to have
symptomatic infectious diseases more often and longer than non‐immunocompromised …

Background The COVIH study is a prospective coronavirus disease 2019 (COVID-19)
vaccination study in 1154 people with HIV (PWH), of whom 14% showed reduced antibody levels …